Circassia Pharmaceuticals PLC (LSE:CIR) - Share price - Overview

Stock Report

Circassia Pharmaceuticals PLC CIR

Last Price
GBX81.25

Day Change
-6.15|-7.04%

As of 19/07/2018
16:53:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close87.40p
Day Range79.80 - 84.30
Mkt Cap312.20Mil
52-Wk Range76.75 - 113.50
Yield %-
ISINGB00BJVD3B28
Volume80,896
P/E-3.61
P/S0.06
P/CF-0.05

Share Price

Total Returns 18/07/2018

 Chg (%)  
More ...
Circassia Pharmaceuticals PLC0.69 
FTSE 100 TR GBP1.18
 
Financials
201520162017
More ...
Income Statement
Turnover10.8023.1046.30
Operating Profit-56.80-43.80-84.70
Net Profit-50.00-36.90-93.60
Reported EPS-20.00-13.00-29.00
Balance Sheet
Current Assets223.70138.4089.90
Non Current Assets265.50195.70312.50
Total Assets489.20334.10402.40
Current Liabilities48.3021.5030.80
Total Liabilities79.5053.40177.60
Total Equity409.70280.70224.80
Cash Flow
Operating Cash Flow-64.90-68.50-66.50
Net Change in Cash135.70-72.70-54.00

Company Profile

Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.

Sector

Biotechnology

Index

FTSE SmallCap ,FTSE All Share

Next Event 27/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-30.54
Op Mrgn-1.83
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Steven Charles Andrew Harris
Non-Executive DirectorDr. Jean-Jacques Garaud
Non-Executive Director, ChairmanDr. Francesco Granata
Executive Director, Chief Financial Officer and Company SecretaryJulien Cotta
Executive Director, Senior Vice President, RandDDr. Rod Hafner
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.